- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
NAG.6: 4 residues within 4Å:- Chain A: R.163, G.234, D.235, N.236
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.163, A:D.235, A:N.236
NAG.7: 1 residues within 4Å:- Chain A: N.29
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.29
NAG.11: 3 residues within 4Å:- Chain B: E.150, N.154, T.156
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.154
NAG.15: 3 residues within 4Å:- Chain C: N.29, T.312
- Chain D: L.52
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain D- Hydrogen bonds: C:N.29, C:T.312
- Hydrophobic interactions: D:L.52
NAG.20: 4 residues within 4Å:- Chain D: S.147, E.150, N.154, T.156
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.154
NAG.22: 2 residues within 4Å:- Chain E: N.29, T.31
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:T.31
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)(Post Translational Modification)
EDO.8: 5 residues within 4Å:- Chain A: Q.262, W.277, R.278, R.294
- Chain B: E.69
Ligand excluded by PLIPEDO.9: 3 residues within 4Å:- Chain A: H.49, K.50, D.51
Ligand excluded by PLIPEDO.10: 8 residues within 4Å:- Chain A: L.61, L.171, I.172, M.173, P.248, R.250, V.251, S.252
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: P.293, Y.302
- Chain B: K.85, I.88, T.89
- Chain F: W.83
- Ligands: EDO.14
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: T.295, K.301
- Chain B: F.63
- Chain F: W.83
- Ligands: EDO.14
Ligand excluded by PLIPEDO.14: 8 residues within 4Å:- Chain A: K.301
- Chain B: F.63, I.88, W.92
- Chain F: W.83, S.87
- Ligands: EDO.12, EDO.13
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain C: I.261, Q.262, W.277, R.278, R.294
- Chain D: E.69
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain C: S.48, T.74, W.75, D.76
Ligand excluded by PLIPEDO.18: 8 residues within 4Å:- Chain C: L.61, L.171, I.172, M.173, P.248, R.250, V.251, S.252
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain B: N.79
- Chain C: Q.101, M.104, E.105
- Chain D: E.64, S.65
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain D: E.72, H.75
- Chain E: K.102
Ligand excluded by PLIPEDO.23: 8 residues within 4Å:- Chain E: L.61, L.171, I.172, M.173, P.248, R.250, V.251, S.252
Ligand excluded by PLIPEDO.24: 10 residues within 4Å:- Chain C: V.210, G.212, A.213, R.214
- Chain E: S.197, V.198, G.199, Q.204, T.238, S.240
Ligand excluded by PLIPEDO.25: 7 residues within 4Å:- Chain E: L.146, F.155, Y.189, H.241, G.243, G.244, L.245
Ligand excluded by PLIPEDO.26: 7 residues within 4Å:- Chain D: W.83
- Chain E: P.293, Y.302
- Chain F: K.85, I.88, T.89
- Ligands: EDO.27
Ligand excluded by PLIPEDO.27: 5 residues within 4Å:- Chain D: W.83
- Chain E: T.295, K.301
- Chain F: F.63
- Ligands: EDO.26
Ligand excluded by PLIPEDO.28: 7 residues within 4Å:- Chain B: L.98, M.102
- Chain D: L.98, M.102
- Chain F: Q.95, L.98, M.102
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain E: L.6, G.7, H.8
- Chain F: I.10, N.12, G.13, W.14
Ligand excluded by PLIP- Links
- RCSB PDBe PDBj PDBsum CATH PLIP
- Citation
- Vachieri, S.G. et al., Receptor Binding by H10 Influenza Viruses. Nature (2014)
- Release Date
- 2014-06-11
- Peptides
- HEMAGGLUTININ: ACE
HEMAGGLUTININ: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Non-functional Binders)
- 6 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-functional Binders)
- 18 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)(Post Translational Modification)
- Links
- RCSB PDBe PDBj PDBsum CATH PLIP
- Citation
- Vachieri, S.G. et al., Receptor Binding by H10 Influenza Viruses. Nature (2014)
- Release Date
- 2014-06-11
- Peptides
- HEMAGGLUTININ: ACE
HEMAGGLUTININ: BDF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
F